Medicamen Biotec

{
  "main_header": {
    "sid": 770569,
    "name": "Medicamen Biotec",
    "stock_name": "Medicamen Biotec",
    "full_name": "Medicamen Biotech Ltd",
    "name_url": "stocks-analysis/medicamen-biotec",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "228.97",
    "chg": -2.67,
    "chgp": "-1.15%",
    "dir": -1,
    "prev_price": "231.64",
    "mcapval": "322.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531146,
    "symbol": "MEDICAMEQ",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE646B01010",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "89.27 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medicamen-biotec-770569-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Medicamen Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-ltd-is-rated-strong-sell-3930156",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MedicamenBiotec_mojoScore_3930156.png",
        "date": "2026-04-02 10:10:29",
        "description": "Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and technical outlook."
      },
      {
        "title": "Medicamen Biotech Ltd Falls to 52-Week Low of Rs 225 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-falls-to-52-week-low-amid-continued-downtrend-3924557",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_priceRelatedfactors_3924557.png",
        "date": "2026-03-30 11:46:12",
        "description": "For the second consecutive session, Medicamen Biotech Ltd has seen its share price slide further, hitting a fresh 52-week low of Rs 225 on 30 Mar 2026. This decline extends a recent losing streak that has erased nearly 10% of its value over two days, underscoring persistent selling pressure amid a challenging market backdrop."
      },
      {
        "title": "Medicamen Biotech Ltd Falls to 52-Week Low of Rs 234.35 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-falls-to-52-week-low-amid-continued-downtrend-3920353",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_priceRelatedfactors_3920353.png",
        "date": "2026-03-27 15:55:50",
        "description": "A sharp decline in Medicamen Biotech Ltd has pushed the stock to a fresh 52-week low of Rs 234.35 on 27 Mar 2026, marking a significant 47.95% drop over the past year. This downturn comes amid broader market weakness and persistent underperformance relative to benchmarks and peers."
      },
      {
        "title": "Five Consecutive Losses Push Medicamen Biotech Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-stock-falls-to-52-week-low-of-rs24325-3907225",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_priceRelatedfactors_3907225.png",
        "date": "2026-03-23 11:00:31",
        "description": "For the fifth consecutive session, Medicamen Biotech Ltd has closed lower, hitting a fresh 52-week low of Rs 243.25 on 23 Mar 2026. This decline comes amid a broader sector downturn but marks a significant underperformance relative to the market and peers."
      },
      {
        "title": "Five Consecutive Losses Push Medicamen Biotech Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-stock-hits-52-week-low-amid-continued-downtrend-3907223",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_priceRelatedfactors_3907223.png",
        "date": "2026-03-23 11:00:29",
        "description": "For the fifth consecutive session, Medicamen Biotech Ltd has closed lower, slipping to a fresh 52-week low of Rs 243.25 on 23 Mar 2026. This decline comes amid a broader sector weakness but is notably sharper than the overall Pharmaceuticals & Biotechnology sector's fall of 3.16% today."
      },
      {
        "title": "Medicamen Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-ltd-is-rated-strong-sell-3905876",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_mojoScore_3905876.png",
        "date": "2026-03-22 10:10:24",
        "description": "Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 February 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 23 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Medicamen Biotech Ltd Falls to 52-Week Low of Rs 260.3 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-stock-falls-to-52-week-low-of-rs2603-3903030",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_priceRelatedfactors_3903030.png",
        "date": "2026-03-20 11:13:53",
        "description": "For the second consecutive session, Medicamen Biotech Ltd has seen its share price decline, hitting a fresh 52-week low of Rs 260.3 on 20 Mar 2026. This latest drop extends the stock’s downward trajectory, which has now resulted in a 3.93% loss over the past two days, underperforming its sector by 1.51% today."
      },
      {
        "title": "Medicamen Biotech Ltd Falls to 52-Week Low of Rs.262.5 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-falls-to-52-week-low-of-rs2625-amidst-continued-downtrend-3900282",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_priceRelatedfactors_3900282.png",
        "date": "2026-03-19 10:19:13",
        "description": "Medicamen Biotech Ltd’s shares declined to a fresh 52-week low of Rs.262.5 on 19 Mar 2026, marking a significant drop amid broader market weakness and company-specific performance concerns. The stock underperformed its sector and key benchmarks, reflecting ongoing challenges in sustaining growth momentum."
      },
      {
        "title": "Medicamen Biotech Ltd Falls to 52-Week Low of Rs.263.65",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-falls-to-52-week-low-of-rs26365-3893685",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_priceRelatedfactors_3893685.png",
        "date": "2026-03-16 11:20:15",
        "description": "Medicamen Biotech Ltd has reached a new 52-week low of Rs.263.65 today, marking a significant decline in its stock price amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and valuation metrics."
      }
    ],
    "total": 6230,
    "sid": "770569",
    "stock_news_url": "https://www.marketsmojo.com/news/medicamen-biotech-770569"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Medicamen Biotech Ltd has declared <strong>10%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Medicamen Biotech Ltd is Rated Strong Sell

2026-04-02 10:10:29

Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and technical outlook.

Read full news article

Medicamen Biotech Ltd Falls to 52-Week Low of Rs 225 as Sell-Off Deepens

2026-03-30 11:46:12

For the second consecutive session, Medicamen Biotech Ltd has seen its share price slide further, hitting a fresh 52-week low of Rs 225 on 30 Mar 2026. This decline extends a recent losing streak that has erased nearly 10% of its value over two days, underscoring persistent selling pressure amid a challenging market backdrop.

Read full news article

Medicamen Biotech Ltd Falls to 52-Week Low of Rs 234.35 as Sell-Off Deepens

2026-03-27 15:55:50

A sharp decline in Medicamen Biotech Ltd has pushed the stock to a fresh 52-week low of Rs 234.35 on 27 Mar 2026, marking a significant 47.95% drop over the past year. This downturn comes amid broader market weakness and persistent underperformance relative to benchmarks and peers.

Read full news article

Five Consecutive Losses Push Medicamen Biotech Ltd to a New 52-Week Low

2026-03-23 11:00:31

For the fifth consecutive session, Medicamen Biotech Ltd has closed lower, hitting a fresh 52-week low of Rs 243.25 on 23 Mar 2026. This decline comes amid a broader sector downturn but marks a significant underperformance relative to the market and peers.

Read full news article

Five Consecutive Losses Push Medicamen Biotech Ltd to a New 52-Week Low

2026-03-23 11:00:29

For the fifth consecutive session, Medicamen Biotech Ltd has closed lower, slipping to a fresh 52-week low of Rs 243.25 on 23 Mar 2026. This decline comes amid a broader sector weakness but is notably sharper than the overall Pharmaceuticals & Biotechnology sector's fall of 3.16% today.

Read full news article

Medicamen Biotech Ltd is Rated Strong Sell

2026-03-22 10:10:24

Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 February 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 23 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Medicamen Biotech Ltd Falls to 52-Week Low of Rs 260.3 as Sell-Off Deepens

2026-03-20 11:13:53

For the second consecutive session, Medicamen Biotech Ltd has seen its share price decline, hitting a fresh 52-week low of Rs 260.3 on 20 Mar 2026. This latest drop extends the stock’s downward trajectory, which has now resulted in a 3.93% loss over the past two days, underperforming its sector by 1.51% today.

Read full news article

Medicamen Biotech Ltd Falls to 52-Week Low of Rs.262.5 Amidst Continued Downtrend

2026-03-19 10:19:13

Medicamen Biotech Ltd’s shares declined to a fresh 52-week low of Rs.262.5 on 19 Mar 2026, marking a significant drop amid broader market weakness and company-specific performance concerns. The stock underperformed its sector and key benchmarks, reflecting ongoing challenges in sustaining growth momentum.

Read full news article

Medicamen Biotech Ltd Falls to 52-Week Low of Rs.263.65

2026-03-16 11:20:15

Medicamen Biotech Ltd has reached a new 52-week low of Rs.263.65 today, marking a significant decline in its stock price amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and valuation metrics.

Read full news article

View All News